Cypherpunk Technologies (CYPH): Warrant Overhang

A failed cancer-drug company that cut 75% of its staff and slashed quarterly R&D spending 98% renamed itself four months later into a Zcash treasury vehicle, and now reports just six employees.

Nearly 90% of its reported assets are not directly held crypto but a contractual claim on a custodian affiliated with the Winklevoss twins, who also control the investor group that financed the pivot and sit on multiple sides of its transactions. Fugazi Research, which holds a short position in the stock, argues that warrants and restricted stock already outnumber Cypherpunk's common shares outstanding and that continued dilution could leave public holders with worse Zcash exposure than owning the token directly.

Ticker: CYPH (Cypherpunk Technologies Inc.)
Research Firm: Fugazi Research
Report URL: https://www.fugaziresearch.com/p/cyph-incinerating-your-money-for?ref=shortreport.fyi
Report date: 2026-11-09
Position Disclosure: Short position. Fugazi Research states Cypherpunk common stock is "uninvestable at any price above zero."

Published by Fugazi Research on 2026-11-09.

The Short Report's Take

The strongest material here is documented, not inferred. Cypherpunk's own 10-K discloses that Gemini Space Sciences, a Winklevoss Capital affiliate, holds its Zcash in omnibus wallets tracked on an internal ledger, that the company could become a general unsecured creditor if that custodian fails, and that its auditor, EisnerAmper, flagged the related-party receivable as a Critical Audit Matter. Combined with a documented warrant and RSU count that exceeds the common share base, this is the part of the case a holder can verify directly in the filings rather than take on faith.

The weaker links are inferential. Fugazi's claim that actual shares outstanding may already be closer to 149 million, well above the 129.27 million it can document, rests on backing into WTI's ownership cap rather than a disclosed share count, and the firm labels it circumstantial. Its broader argument that a "Winklevoss pattern" of insiders retaining cheap stock while public holders absorb losses will repeat at Cypherpunk draws on Gemini's share-price history, which is a comparison, not proof of outcome. The report cites no regulator or auditor action against Cypherpunk itself, and the company had not responded at publication.

The source report does not state Cypherpunk's share-price reaction or short interest following publication, so that remains unknown to readers of this report.

Related coverage on The Short Report:

Thesis

Fugazi Research argues Cypherpunk Technologies is a failed oncology biotech repackaged as a Zcash treasury company whose equity-funded strategy, custody structure, and Winklevoss-affiliated governance expose public shareholders to dilution and loss.

Biotech Rebrand: Leap Therapeutics carried a $500.33 million accumulated deficit, cut roughly 75% of its workforce on June 23, 2025, and saw quarterly R&D spending fall 98.1% to $197,000 before renaming itself Cypherpunk Technologies on November 12, 2025.
Custodian Claim, Not Crypto: At December 31, 2025, approximately 90% of total assets were a related-party digital-assets receivable tied to Gemini Space Sciences, a Winklevoss Capital affiliate, with no FDIC or SIPC protection and flagged by auditor EisnerAmper as a Critical Audit Matter.
Related-Party Mining Deal: Winklevoss Treasury Investments received a pre-funded warrant for 43,290,042 shares in exchange for $33.33 million of Moria Mining equipment, with no disclosed fairness opinion found by the report; Moria's contact, Kevin Zhang, became Cypherpunk's Head of Mining the next day.
Dilution Overhang: Warrants covering 158.68 million shares, equal to 147% of the 107.76 million common shares outstanding at June 30, 2026, sit alongside 16.58 million outstanding RSUs and an authorized-share increase to 500 million.
Hidden Share Count: WTI's October exercise under its 19.99% ownership cap implies roughly 149 million shares outstanding, well above the 129.27 million the author can directly document.
Unrealized-Gain Profit: Second-quarter 2026 net income of $39.39 million included a $45.99 million unrealized fair-value gain on the ZEC derivative; excluding it, the quarter shows an approximately $6.60 million loss.
Equity-Funded Treasury: Cash fell 45.7% to $7.62 million in six months while the company sold 49.34 million shares through its Cantor ATM for about $71.01 million, and its liquidity plan leans on the facility's remaining capacity.
Winklevoss Insider Pattern: The report alleges WTI bought into the October 2025 PIPE at roughly $0.52 per share while public investors paid about 5.5 times that, drawing a parallel to Gemini, where the twins kept 94.5% of voting power as Class A shares fell from $28 to $2.39.

Catalysts

Further sales under the roughly $128 million of remaining capacity on the $200 million Cantor ATM: ongoing, would add to the documented share count.
Exercise of warrants covering 158.68 million shares, including pre-funded warrants at $0.001 and common warrants at $0.5335: next quarterly filing, would convert the overhang into actual shares.
Issuance under the 43.29 million-share Moria Mining warrant: ongoing, adds to dilution tied to the related-party transaction.
Vesting of the 16.58 million outstanding RSUs, with $13.86 million of unrecognized compensation cost: upcoming vesting periods, adds further share issuance.
Cypherpunk's next quarterly filing: pending, could confirm whether shares outstanding are materially above the 107.76 million last reported.
Movement in ZEC's price: ongoing, directly affects the digital-assets receivable and the unrealized derivative gains or losses driving reported net income.
Any disclosure of Gemini custody terms, segregation, insurance, or proof of reserves: pending, would clarify Cypherpunk's standing in a custodian-stress scenario.

Company Response

The report describes no request for comment to Cypherpunk, Gemini, WTI, the Winklevoss twins, or Moria Mining, and includes no company response to its findings.

Notable Details

Cypherpunk reports just six employees overseeing its Zcash treasury strategy, custody relationship, mining acquisition, and $200 million ATM program.
A Form 144 filed August 26, 2026 still cited the company's older 107,764,382-share count, even as the report's analysis suggests millions of additional shares may have already been issued.
Gemini's Class A shares, sold to the public at $28 in September 2025, closed at $2.39 on November 5, 2026, while the Winklevoss twins retained roughly 94.5% of voting power through Class B shares.
The SEC dismissed its case against Gemini with prejudice on January 23, 2026 without a penalty, after New York regulators had already fined Gemini $37 million and required it to return at least $1.1 billion to Earn customers.

"You can buy Zcash directly. Buying CYPH just means paying a premium to get diluted."
This appears in the report's conclusion and summarizes Fugazi Research's central argument against owning the stock instead of the underlying token.

FAQs

What does CYPH's $129 million Zcash position actually consist of?

Cypherpunk reported 323,394.38 ZEC at June 30, 2026, carried as a $129.39 million digital-assets receivable rather than directly controlled tokens. The position is held through Gemini Space Sciences in pooled omnibus wallets with ownership tracked on an internal ledger, and the company's own 10-K warns it could be treated as a general unsecured creditor if the custodian becomes insolvent.

What was Cypherpunk Technologies before it became a crypto company?

Cypherpunk was formerly Leap Therapeutics, a clinical-stage oncology company that developed Sirexatamab (formerly DKN-01) and FL-501 without ever winning FDA approval or generating product sales. Its board approved a research wind-down and roughly 75% workforce reduction on June 23, 2025, and the company changed its name and ticker from LPTX to CYPH on November 12, 2025.

What does Fugazi Research allege about Cypherpunk's share count?

Fugazi Research calculates that WTI's October 2026 warrant exercise, measured against its 19.99% ownership blocker, implies roughly 149 million shares outstanding, compared with about 129.27 million the firm can document directly. The firm flags this gap as circumstantial, noting an August 26 Form 144 still cited the older 107,764,382-share figure.

Why does Cypherpunk's custody arrangement with Gemini matter?

Gemini Space Sciences, which executes and custodies Cypherpunk's ZEC trades, is an affiliate of Winklevoss Capital, the same network that led Cypherpunk's financing and designates two of its directors. The arrangement carries no FDIC or SIPC protection, and Cypherpunk's auditor, EisnerAmper, identified the related accounting as a Critical Audit Matter.

How much dilution could CYPH shareholders face from warrants and RSUs?

At June 30, 2026, warrants covered 158.68 million shares against 107.76 million common shares outstanding, a ratio of 147%, and 16.58 million RSUs remained outstanding with $13.86 million in unrecognized compensation cost. An August mining transaction added a further 43.29 million-share warrant on top of that total.

Is Cypherpunk's reported profit from operations or from Zcash price moves?

Cypherpunk's $39.39 million second-quarter 2026 net income included a $45.99 million unrealized fair-value gain on its ZEC derivative; excluding that gain, the quarter shows an approximate $6.60 million loss. For the first half of 2026, the company reported a $37.78 million net loss that included a $31.56 million net unrealized derivative loss.

What is the Winklevoss connection to Cypherpunk?

Winklevoss Treasury Investments led Cypherpunk's $58.89 million October 2025 private placement and designated two directors, William McEvoy and Khing Oei, while McEvoy, a Winklevoss Capital principal, also became Cypherpunk's Chief Investment Officer. The same network supplies Cypherpunk's custody provider (Gemini Space Sciences) and sold it mining equipment through WTI in exchange for a 43.29 million-share warrant.

Has Cypherpunk responded to the short report?

The report does not describe any response from Cypherpunk to its findings, and it states that no request for comment to the company or its affiliated parties is included in its research process.

Disclaimer: This summary is not primary research and does not constitute investment advice. It is a brief overview of a detailed equity research report authored by the firm, organization, or source referenced in this article or at https://www.fugaziresearch.com/p/cyph-incinerating-your-money-for, which contains extensive evidence, regulatory filings, and analysis; readers are encouraged to review the full report there for a comprehensive understanding. The content provided in this publication is not authored or originated by us — we act solely as a distributor and do not endorse, verify, or take responsibility for the accuracy, completeness, or reliability of the information presented. This publication is for informational purposes only and should not be construed as legal, business, investment, or tax advice. Always conduct independent due diligence and consult qualified professionals before making any decisions based on the information contained herein. We disclaim all liability for any loss or damage arising from reliance on third-party content, and the views expressed are solely those of the respective source and do not necessarily reflect our own.